Items tagged with Drug-resistant TB
Practice-based recommendations for the management of RR/MDR-TB (post with simple image)
Statement from DR-TB STAT and TAG outlining practice-based recommendations for the optimal management of RR/MDR-TB.
MSF technical brief: Making the switch (post with simple image)
Saving more lives with optimal treatment for drug-resistant TB.
TB drug delamanid must be more affordable and made available in more countries (post with simple image)
Médecins Sans Frontières acknowledges the lower price offered to the government of South Africa for delamanid, but calls for it to be significantly lower and expanded to all countries in need.
Global campaign launched urging Johnson & Johnson to reduce price of bedaquiline (post with simple image)
Médecins Sans Frontières launches a global campaign calling on Johnson & Johnson to lower the price of bedaquiline to no more than US$1 per day.
DR-TB Drugs Under the Microscope, 6th edition (post with simple image)
Médecins Sans Frontières releases the 6th edition of DR-TB Drugs Under the Microscope: 5 Urgent Actions to Improve DR-TB Treatment.
Civil society demands affordability, transparency and accountability from the TB Alliance (post with simple image)
Civil society activists storm the stage at The Union Conference to demand affordability, transparency and accountability from the TB Alliance.
TB activists disrupt opening of The Union Conference to protest drug corporations keeping life-saving medicines from people (post with simple image)
Newer medicines for drug-resistant TB are desperately needed, but barriers to access, including high prices, keep them out of reach for most people around the world.
Price announced for new lifesaving TB drug pretomanid still too high (post with simple image)
Pretomanid is just one part of a regimen of multiple drugs that people need. MSF has been calling for the price of a complete DR-TB treatment course to be no higher than $500 per person.
Are pretomanid-containing regimens for TB a victory or a victory narrative? (post with simple image)
"Given the evidence base available to us currently, can we claim pretomanid a victory? We think more research is needed before pretomanid can be celebrated as a promising treatment for people with tuberculosis."
ATS, CDC, ERS and IDSA publish new clinical guideline for the treatment and prevention of drug-resistant TB (post with simple image)
New guideline emphasizes treatment of drug-resistant TB with all-oral regimens and provides recommendations for treatment of all contacts to multidrug-resistant TB patients.
Page 88 of 89 · Total posts: 0←First 87 88 89 Last→